The relative influence of secondary versus primary prevention using the National Cholesterol Education Program Adult Treatment Panel II guidelines
نویسندگان
چکیده
منابع مشابه
The National Cholesterol Education Program Adult Treatment Panel III guidelines.
Coronary heart disease (CHD) persists as a major cause of morbidity and mortality in the United States, with more than 40% of all deaths each year directly attributed to the disease. Dyslipidemia is recognized as a major risk factor for the development and progression of CHD, with clinical trials clearly demonstrating the public health and economic benefits of favorable cholesterol modification...
متن کاملImplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
The Adult Treatment Panel III (ATP III) of the National Cholesterol Education Program issued an evidence-based set of guidelines on cholesterol management in 2001. Since the publication of ATP III, 5 major clinical trials of statin therapy with clinical end points have been published. These trials addressed issues that were not examined in previous clinical trials of cholesterol-lowering therap...
متن کاملThe National Cholesterol Education Program Adult Treatment Panel Iii—how Do Women Fit In?
The National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP) released initial guidelines in 1988 (ATP I), followed by ATP II in 1993 and ATP III in 2001. In ATP I and II, treatment recommendations and goals of therapy for secondary prevention are similar. However, ATP III established a more aggressive approach for both secondary prevention and higher risk primary-prevention pat...
متن کاملRecommendations of the Adult Treatment Panel of the National Cholesterol Education Program. Implications for the management of hypertension.
HYPERTENSION is recognized as a major cardiovascular risk factor. Multiple clinical trials have shown that the treatment of high blood pressure reduces the incidence of stroke, congestive heart failure, and perhaps, renal insufficiency. However, these trials failed to demonstrate a consistent impact of antihypertensive therapy on coronary heart disease events. Although the exact reasons for thi...
متن کاملRecommendations of the Adult Treatment Panel of the National Cholesterol Education Program Implications for the Management of Hypertension
HYPERTENSION is recognized as a major cardiovascular risk factor. Multiple clinical trials have shown that the treatment of high blood pressure reduces the incidence of stroke, congestive heart failure, and perhaps, renal insufficiency. However, these trials failed to demonstrate a consistent impact of antihypertensive therapy on coronary heart disease events. Although the exact reasons for thi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Cardiology
سال: 1999
ISSN: 0735-1097
DOI: 10.1016/s0735-1097(99)00260-0